Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Ugeskrift for Laeger
|
September 5, 2024
Jakob Mejdahl Bentin, Lars Arendt-Nielsen, Asger Reinstrup Bihlet
European Journal of Clinical Pharmacology
|
January 6, 2016
The impact of clinical trial monitoring approaches on data integrity and cost--a review of current literature
Rasmus Olsen, Asger Reinstrup Bihlet, Faidra Kalakou, et al.
Seminars in Arthritis and Rheumatism
|
October 15, 2020
A novel diclofenac gel (AMZ001) applied once or twice daily in subjects with painful knee osteoarthritis: A randomized, placebo-controlled clinical trial
Asger Reinstrup Bihlet, Inger Byrjalsen, Lee S Simon, et al.
Journal of Proteomics
|
April 29, 2018
Protein biomarkers associated with pain mechanisms in osteoarthritis
Christian S Thudium, Henrik Löfvall, Morten A Karsdal, et al.
Osteoarthritis and Cartilage Open
|
February 6, 2026
Investigating predictors of pain events during trials of knee osteoarthritis: A post-hoc analysis of two phase III trials
Andrea Bak Kaaber, Jakob Mejdahl Bentin, Ida Sofie Adrian, et al.
British Journal of Clinical Pharmacology
|
December 8, 2022
Impact of monitoring approaches on data quality in clinical trials
Jeppe Ragnar Andersen, Christoffer von Sehested, Inger Byrjalsen, et al.
Osteoarthritis and Cartilage Open
|
September 17, 2024
Unbiased analysis of knee cartilage thickness change over three years after sprifermin vs. placebo treatment - A post-hoc analysis from the phase 2B FORWARD study
Felix Eckstein, Susanne Maschek, Wolfgang Wirth, et al.
Clinical and Experimental Rheumatology
|
March 3, 2022
Symptomatic and structural benefit of cathepsin K inhibition by MIV-711 in a subgroup with unilateral pain: post-hoc analysis of a randomised phase 2a clinical trial
Asger Reinstrup Bihlet, Inger Byrjalsen, Jeppe Ragnar Andersen, et al.
Seminars in Arthritis and Rheumatism
|
April 7, 2020
Clinical and biochemical factors associated with risk of total joint replacement and radiographic progression in osteoarthritis: Data from two phase III clinical trials
Asger Reinstrup Bihlet, Jonathan Jetsmark Bjerre-Bastos, Jeppe Ragnar Andersen, et al.
Respiratory Research
|
January 21, 2017
Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD
Asger Reinstrup Bihlet, Morten Asser Karsdal, Jannie Marie Bülow Sand, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Ugeskrift for Laeger
|
September 5, 2024
Jakob Mejdahl Bentin, Lars Arendt-Nielsen, Asger Reinstrup Bihlet
European Journal of Clinical Pharmacology
|
January 6, 2016
The impact of clinical trial monitoring approaches on data integrity and cost--a review of current literature
Rasmus Olsen, Asger Reinstrup Bihlet, Faidra Kalakou, et al.
Seminars in Arthritis and Rheumatism
|
October 15, 2020
A novel diclofenac gel (AMZ001) applied once or twice daily in subjects with painful knee osteoarthritis: A randomized, placebo-controlled clinical trial
Asger Reinstrup Bihlet, Inger Byrjalsen, Lee S Simon, et al.
Journal of Proteomics
|
April 29, 2018
Protein biomarkers associated with pain mechanisms in osteoarthritis
Christian S Thudium, Henrik Löfvall, Morten A Karsdal, et al.
Osteoarthritis and Cartilage Open
|
February 6, 2026
Investigating predictors of pain events during trials of knee osteoarthritis: A post-hoc analysis of two phase III trials
Andrea Bak Kaaber, Jakob Mejdahl Bentin, Ida Sofie Adrian, et al.
British Journal of Clinical Pharmacology
|
December 8, 2022
Impact of monitoring approaches on data quality in clinical trials
Jeppe Ragnar Andersen, Christoffer von Sehested, Inger Byrjalsen, et al.
Osteoarthritis and Cartilage Open
|
September 17, 2024
Unbiased analysis of knee cartilage thickness change over three years after sprifermin vs. placebo treatment - A post-hoc analysis from the phase 2B FORWARD study
Felix Eckstein, Susanne Maschek, Wolfgang Wirth, et al.
Clinical and Experimental Rheumatology
|
March 3, 2022
Symptomatic and structural benefit of cathepsin K inhibition by MIV-711 in a subgroup with unilateral pain: post-hoc analysis of a randomised phase 2a clinical trial
Asger Reinstrup Bihlet, Inger Byrjalsen, Jeppe Ragnar Andersen, et al.
Seminars in Arthritis and Rheumatism
|
April 7, 2020
Clinical and biochemical factors associated with risk of total joint replacement and radiographic progression in osteoarthritis: Data from two phase III clinical trials
Asger Reinstrup Bihlet, Jonathan Jetsmark Bjerre-Bastos, Jeppe Ragnar Andersen, et al.
Respiratory Research
|
January 21, 2017
Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD
Asger Reinstrup Bihlet, Morten Asser Karsdal, Jannie Marie Bülow Sand, et al.
Page
of 3